Company intelligence / Profile preview

Latham BioPharm Group

Elkridge, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Latham BioPharm Group is a leading life sciences consulting firm providing expertise in product development, non-dilutive funding strategies, and strategic consulting for pharmaceutical, biotech, CROs, academia, and medical device/diagnostic companies. They have supported the advancement of numerous life science products and helped secure over $2.5 billion in non-dilutive funding for clients.

Modalities: Cell therapyGene therapyVaccine (general)Therapeutic products (general)
Industry: Consulting

Partnerships

National Institute of Allergy and Infectious Diseases (NIAID) / NIH – awarded IDIQ contract for preclinical biopharmaceutical product development services

Beyond the preview

Go deeper on Latham BioPharm Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Latham BioPharm Group.

Explore the full profile